<DOC>
	<DOCNO>NCT00852995</DOCNO>
	<brief_summary>This 16-week study subject venous leg ulcer knee ankle . This research do determine effectiveness two dose frequency two different concentration HP802-247 , together standard care , compare placebo , plus standard care .</brief_summary>
	<brief_title>Dose Finding Study HP802-247 Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<criteria>Provide inform consent . Willing comply protocol instruction , include allow study assessment . Have venous leg ulcer ( venous etiology ) knee ankle , malleolus . Venous insufficiency confirm duplex Doppler ultrasound examination valvular venous incompetence . Target ulcer duration great equal 6 week less equal 24 month . Women pregnant lactate Therapy another investigational agent within thirty ( 30 ) day Screening , study . A target ulcer nonvenous etiology . Refusal inability tolerate compression therapy . Therapy target ulcer tissueengineered cellbased skin equivalent within 30 day precede Screening Visit . Therapy target ulcer topical growth factor within 1 week precede Screening Visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Venous Leg Ulcer ( VLU )</keyword>
	<keyword>Venous Stasis Ulcer ( VSU )</keyword>
	<keyword>VLU</keyword>
	<keyword>VSU</keyword>
	<keyword>Leg Ulcer</keyword>
	<keyword>Leg Wound</keyword>
</DOC>